The core activity of EuroVacc is the development of safe and effective vaccines against HIV and other infectious diseases through the promotion and support of international collaborations with leading vaccine researchers and developers in the public and private sectors.
AI-generated
Offering
Products & services
Industry:Pharmaceutical Industry
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Vaccine research against HIV and other infectious diseases, with translational development from discovery to early clinical development and collaboration with academic and industrial partners.
Support for Phase I/II Clinical Trials
Support and sponsorship of Phase I/II studies in Europe and Africa, including prophylactic and therapeutic HIV vaccine trials.
Scientific Project Management
Scientific project management for large research consortia, supporting development, manufacturing, regulatory work and clinical trials in infectious diseases.
International Research Collaborations
International collaborations with academic, public and private partners to advance vaccine candidates against HIV and other infectious diseases.
Scientific Publication of Results
Publication of scientific results on HIV vaccines and other infectious diseases in journals and conference contributions.
Research Funding Support
Securing and managing research grants and funding to support medical research against AIDS and other infectious diseases.
Comparisons
FONDATION EUROVACC in comparison
Soon
Industry comparisons are coming soon
We're preparing industry comparisons that rank FONDATION EUROVACC by reviews, experience and specialisations.
Knowledge
No knowledge articles yet
Once FONDATION EUROVACC has claimed this profile, we'll publish editorial articles and case studies here together.